The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
CheckMate 602: An open-label, randomized, phase 3 trial of combinations of nivolumab, elotuzumab, pomalidomide and dexamethasone in relapsed/refractory multiple myeloma.
 
Sagar Lonial
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen Oncology; Millennium; Novartis; Onyx; Sanofi
 
Paul G. Richardson
Consulting or Advisory Role - Genmab
Research Funding - Celgene; Millennium
 
Donna Ellen Reece
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Janssen; Merck; Millennium; Novartis; Otsuka
Expert Testimony - Amgen; Janssen; Millennium
 
Hesham Mohamed
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Suresh Shelat
No Relationships to Disclose
 
Jesus San Miguel
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; CELGENE; Janssen-Cilag; MSD; Novartis; Takeda